Myeloid Cells: Orchestrators of Immunity in Health, Disease and Therapy (C3)
March 15-18, 2027
| INEC Killarney Convention Centre, Killarney, KY, Ireland
Julie Helft, Matthew Collin and Christine Carine Moussion
| 4:00–8:00 PM |
Registration |
|
| 6:00–8:00 PM |
Welcome Mixer |
|
| 8:00–9:00 AM |
Welcome and Keynote Address |
|
| |
Florent Ginhoux †, Gustave Roussy
Mapping Myeloid Cell Ontogeny and Function |
|
| 9:00–11:15 AM |
Myeloid Cells Origin and Lineages |
|
| |
Venetia Bigley †, Newcastle University
Genetic Determinant of Human Myeloid Cell Lineage Specification |
|
| |
Steffen Jung †, Weizmann Institute of Science
Monocyte Development and Fate in Tissues |
|
| |
Chrysothemis Brown †, Sloan Kettering Institute
Early Life Immune Development (RORgt Dendritic Cells) |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 9:30–9:50 AM |
Coffee Break |
|
| 11:15–12:15 PM |
Meet the Editors |
|
| 11:15–1:00 PM |
Poster Setup |
|
| 11:15–5:00 PM |
On Own for Lunch |
|
| 1:00–10:00 PM |
Poster Viewing |
|
| 2:30–4:30 PM |
Symposia Spotlight 1: Late-Breaking Research |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 4:30–5:00 PM |
Coffee Available |
|
| 5:00–7:00 PM |
Myeloid Cell Development in Disease States |
|
| |
Miriam Merad †, Mount Sinai School of Medicine
Myelopoiesis Regulation in Aging |
|
| |
Matthew Collin, Newcastle University
Human Dendritic Cell Diversification in Inflammation and Neoplasia |
|
| |
Pierre Guermonprez †, Institut Pasteur
Plasmacytoid Dendritic Cell Development during Immune Checkpoint Blockade Cancer-Therapy |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 7:00–8:00 PM |
Social Hour with Dinner |
|
Wednesday, March 17, 2027
| 8:00–11:00 AM |
Myeloid Cells Across Tissues and Microenvironments |
|
| |
Christine Carine Moussion, Genentech, Inc.
Imaging Dendritic Cell Dynamics in the Skin |
|
| |
Martin Guilliams †, Ghent University - VIB
Mapping and Harnessing Myeloid Cells in Liver Pathology |
|
| |
Andrés Hidalgo †, Yale School of Medicine
Neutrophil Roles in Physiology and Pathology of the Organism |
|
| |
Isabelle C Arnold †, University of Zurich
Eosinophils in the Gut and System Biology |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 9:00–9:20 AM |
Coffee Break |
|
| 11:00–12:00 PM |
Panel Discussion: How to Advance the Therapeutic Targeting of Myeloid Cells |
|
| 11:00–1:00 PM |
Poster Setup |
|
| 11:00–5:00 PM |
On Own for Lunch |
|
| 1:00–10:00 PM |
Poster Viewing |
|
| 3:00–4:30 PM |
Career Roundtable |
|
| 4:30–5:00 PM |
Coffee Available |
|
| 5:00–7:00 PM |
Myeloid Cells at the Neuro-Immune Interface |
|
| |
Nicolas Gaudenzio †, Genoskin
Mast-Cell-Neuron Axis in Skin Allergy |
|
| |
Oleg Butovsky †, Harvard Medical School
Sex-Dependent APOE4 Neutrophil-Microglia Interaction in Neurodegeneration |
|
| |
Caroline Sokol †, Harvard Medical School, Massachusetts General Hospital
Sensory Neuron and Dendritic Cells Migration |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 7:00–8:00 PM |
Social Hour with Dinner |
|
| 8:00–11:00 AM |
Myeloid Cells in Cancer & Immunotherapy |
|
| |
Julie Helft, Institut Cochin
The Role of Perivascular Macrophages in Tumor Immunity |
|
| |
Santiago Pablo Zelenay †, Cancer Research UK, London Research Institute
Dendritic Cells Biology and Inflammatory Circuits in Cancer and Immunotherapy |
|
| |
Mikael J Pittet †, University of Geneva
Neutrophil Response to Tumor in Immunotherapy |
|
| |
Peter Ordentlich †, Syndax Pharmaceuticals, Inc.
The CSF1:CSF1R Pathway in Chronic GVHD |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 9:00–9:20 AM |
Coffee Break |
|
| 11:00–5:00 PM |
On Own for Lunch |
|
| 2:30–4:30 PM |
Symposia Spotlight 2: Spatial and Temporal Orchestration of Myeloid Immunity |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 4:30–5:00 PM |
Coffee Available |
|
| 5:00–7:00 PM |
Myeloid Cells in Infectious Diseases |
|
| |
Niki Moutsopoulos †, NIDCR, National Institutes of Health
Neutrophils in Oral-Barrier Immunity |
|
| |
Menna R Clatworthy †, University of Cambridge
Temporal Profiling of Human Lymphoid Tissues Reveals Coordinated Defense Against Viral Challenge (SARS-CoV2) |
|
| |
Ashley St. John †, Duke-NUS Medical School
Differential Contributions of Fetal Mononuclear Phagocytes to Zika Virus Neuroinvasion versus Neuroprotection during Congenital Infection |
|
| 6:45–7:00 PM |
Meeting Wrap-Up: Outcomes and Future Directions (Organizers) |
|
| 7:00–8:00 PM |
Social Hour with Dinner |
|
| 8:00–11:00 PM |
Entertainment |
|
